Acorda Therapeutics, Inc.

ACOR · NASDAQ
Analyze with AI
3/31/2024
12/31/2023
9/30/2023
6/30/2023
Assets
Cash & Equivalents$9,364$30,360$32,468$25,270
Short-Term Investments$0$0$0$0
Receivables$9,188$17,298$11,977$13,390
Inventory$14,119$16,155$17,942$14,797
Other Curr. Assets$2,447$10,981$10,480$10,629
Total Curr. Assets$48,453$74,794$73,728$64,914
Property Plant & Equip (Net)$5,834$6,300$6,706$6,928
Goodwill$0$0$0$0
Intangibles$22,343$22,987$282,006$289,700
Long-Term Investments$0$255$255$255
Tax Assets$0$9,220-$255-$255
Other NC Assets$4,945$4,189$3,904$3,154
Total NC Assets$33,122$42,951$292,616$299,782
Other Assets$0$0$0$0
Total Assets$81,575$117,745$366,344$364,696
Liabilities
Payables$9,932$14,540$12,330$3,175
Short-Term Debt$193,073$187,731$1,578$1,567
Tax Payable$0$0$0$0
Deferred Revenue$294$227$465$548
Other Curr. Liab.$20,637$26,442$31,921$25,096
Total Curr. Liab.$223,936$227,773$46,294$30,385
LT Debt$2,847$3,166$184,511$179,928
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$9,220$38,544$39,556
Other NC Liab.$40,563$35,542$38,038$46,958
Total NC Liab.$43,410$47,928$261,093$266,443
Other Liabilities$0$0$0$0
Cap. Leases$4,446$3,166$5,046$5,331
Total Liabilities$267,346$275,701$307,387$296,828
Equity
Pref Stock$0$0$0$961,597
Common Stock$1$1$1$1
Retained Earnings-$1,216,522-$1,189,127-$971,366-$962,478
AOCI$875$1,425$717$880
Other Equity$1,029,875$1,029,745$1,029,605$67,868
Total Equity-$185,771-$157,956$58,957$67,868
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$81,575$117,745$366,344$364,696
Net Debt$186,556$160,537$153,621$156,225
Acorda Therapeutics, Inc. (ACOR) Financial Statements & Key Stats | AlphaPilot